Director, Global Commercial Strategy – GI

Johnson & JohnsonHorsham, PA
Hybrid

About The Position

The Director, Global Commercial Commercial Strategy – GI will drive integrated commercial strategy across early discovery through late-stage development assets within the GI portfolio. This role partners closely with GCSO, R&D, Medical Affairs, Market Access, Business Development, and regional commercial teams to embed commercial input early, shape development decisions, advance launch readiness, and maximize long-term asset and portfolio value. This position reports to Sophie Shen, Senior Director, Global Commercial Strategy – Gastroenterology (GI).

Requirements

  • A Bachelor’s degree is required.
  • 10+ years of progressive experience in pharmaceutical, biotech, or healthcare commercial strategy, marketing, business development, market access, medical affairs, R&D strategy, or related functions
  • Demonstrated experience developing commercial strategy for pipeline, early development, late-stage, and/or launch assets, ideally in immunology, gastroenterology, or specialty medicine
  • Strong understanding of drug development, clinical trial design, endpoints, regulatory considerations, evidence generation, market access, and global commercialization requirements
  • Strong strategic thinking, analytical rigor, and business acumen, with ability to translate scientific, clinical, competitive, and market insights into clear commercial implications and actionable recommendations
  • Excellent written and verbal communication skills, including ability to develop executive-ready narratives, synthesize complex information, and present recommendations to senior leadership
  • Demonstrated leadership behaviors consistent with Our Credo and J&J leadership expectations, including accountability, collaboration, inclusion, agility, and enterprise mindset

Nice To Haves

  • An advanced degree preferred, including MBA, PharmD, PhD, MD, or related scientific/business discipline.
  • Proven ability to shape target product profiles, value propositions, asset positioning, competitive strategy, and investment recommendations in partnership with R&D, Medical Affairs, Market Access, GCI, regional teams, and Business Development
  • Experience leading complex, global, cross-functional initiatives in a matrix environment, with the ability to influence senior stakeholders without direct authority

Responsibilities

  • Serve as the commercial lead for early-stage Compound Development Teams (CDTs), embedding commercial strategy from discovery through proof-of-concept to ensure development plans are aligned with DAS roadmap and long-term portfolio value
  • Translate the DAS roadmap into actionable asset-level strategies by defining priority disease spaces, patient segments, clinical value drivers, differentiation requirements, and evidence needs across the early pipeline
  • Shape target product profiles (TPPs), indication sequencing, competitive positioning, and go/no-go criteria to support timely investment decisions and maximize probability of technical, regulatory, and commercial success
  • Provide commercial input into clinical trial design, endpoint selection, comparator strategy, patient enrichment, line-of-therapy positioning, and label-enabling evidence generation for priority GI assets
  • Drive portfolio prioritization across internal programs and external innovation opportunities, integrating unmet need, competitive intensity, mechanism differentiation, market access feasibility, and revenue potential
  • Partner with Business Development, R&D, Medical Affairs, GCI, Market Access, and regions to evaluate external assets, combination strategies, and white-space opportunities that can accelerate or strengthen execution of the GI roadmap
  • Develop executive-ready recommendations for governance forums, including CDT, DAS, IPC, and portfolio reviews
  • Partner with late-development program teams to translate asset strategy into launch-ready commercial plans, including indication prioritization, evidence gaps, competitive readiness, positioning, and value proposition
  • Lead commercial workstreams for late-stage assets, ensuring the launch strategy is grounded with solid forecasting from regional input
  • Shape pre-launch planning across target product profile refinement, launch sequencing, brand positioning, evidence generation, stakeholder engagement, and readiness milestones
  • Partner with cross-functional teams to pressure-test launch assumptions, identify key risks and opportunities, and develop clear recommendations for governance and investment decisions
  • Lead competitive strategy and differentiation planning
  • Partner with R&D and Medical Affairs on scientific narrative and evidence generation
  • Collaborate with Market Access on value and reimbursement strategies for early stage assets
  • Generate actionable insights with GCI to inform strategy
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service